MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0071362
Market Cap
₹27.40 Cr
CSURGSU · BSE
Share Price
₹78.86
+4.99% today
Revenue
₹53.84 Cr
FY 2025-26 · +0.6% YoY
EBITDA
₹5.25 Cr
Margin 9.8%
Net Profit
−₹2.22 Cr
FY 2025-26 · -54.2% YoY
ROE
-7.4%
ROCE 2.3%
Debt / Equity
0.97
Interest cover 280.8x
Authorised capital
₹7.5 Cr
Registered with MCA
About Centenial Surgical Suture Limited
Data last updated:
Centenial Surgical Suture Limited is a public limited company based in Thane, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 20 June 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L99999MH1995PLC089759. Its GSTIN is 27AAACC4639G1ZR (Maharashtra). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 531380.
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹3.65 Cr. It is led by directors including Vijay Kalidas Majrekar (Managing Director) and Anuradha Raghunandan Kashikar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No.F.29 MIDC Industrial Area Murbad, Thane, Maharashtra, India – 421401.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹53.84 Cr, a growth of 0.6% compared to the previous year. For the same year it recorded a net loss of ₹2.22 Cr (net margin -4.1%) and EBITDA of ₹5.25 Cr (EBITDA margin 9.8%). The net worth stands at ₹28.55 Cr (down 7.2% YoY). Total assets are valued at ₹58.93 Cr (down 9.4% YoY).
The company has about 238 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Centenial Surgical Suture. As per MCA filings, the company has open charges of ₹19.25 Cr and satisfied charges of ₹38.5 Cr on record. Court records list 14 cases involving the company, including 11 filed by the company and 3 filed against it; 4 cases are pending. The company has 12 deals on record (8 secondary share transfers, 4 market trades); the latest was in June 2023. Its 3 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Pregna International Limited with revenue of ₹58.91 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 2,053 overdue payments to 35 micro and small suppliers.
Centenial Surgical Suture Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0071362). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website centenialindia.com.
Company details
CIN L99999MH1995PLC089759
Registration Number 089759
Incorporation Date 20 June 1995
ROC Mumbai
Listing Status Listed - Listed on BSE (531380)
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0071362
CIN history
Centenial Surgical Suture has one previous CIN (Corporate Identification Number): U99999MH1995PLC089759. The current CIN is L99999MH1995PLC089759, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L99999MH1995PLC089759 | Current |
| U99999MH1995PLC089759 | Previous |
Key People
Vijay Kalidas Majrekar Managing Director Anuradha Raghunandan Kashikar Whole-Time Director Devraj Poojary Whole-Time Director Recognitions & Rankings of Centenial Surgical Suture
Contact details
Centenial Surgical Suture Limited's registered office is in Thane, Maharashtra. Its website is centenialindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.F.29 MIDC Industrial Area Murbad, Thane, Maharashtra, India – 421401
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Centenial Surgical Suture Limited, buy the company report.
Comprehensive company report
Centenial Surgical Suture Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Centenial Surgical Suture operates one associated brand: Centenial Surgical Suture. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Atraumatic surgical sutures and medical devices are manufactured. | centenialindia.com |
Business activity
The main business activity of Centenial Surgical Suture is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Centenial Surgical Suture Limited, buy the company report.
Financials of Centenial Surgical Suture Limited
FY 2025-26 filings availableCentenial Surgical Suture Limited reported revenue of ₹53.84 Cr (up 0.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹53.84 Cr
+0.6% YoY
EBITDA
₹5.25 Cr
-18.5% YoY
Profit After Tax
−₹2.22 Cr
-54.2% YoY
Net Worth
₹28.55 Cr
-7.2% YoY
Total Assets
₹58.93 Cr
-9.4% YoY
Total Debt
₹27.31 Cr
-9.0% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 53.84 | 53.52 | 51.19 | 52.66 | 44.43 | 36.93 | 55.61 |
| Revenue growth | +0.6% | +4.6% | -2.8% | +18.5% | +20.3% | -33.6% | - |
| EBITDA | 5.25 | 6.44 | 5.16 | 4.40 | 4.48 | 5.11 | 5.92 |
| EBITDA margin | +9.8% | +12.0% | +10.1% | +8.4% | +10.1% | +13.8% | +10.7% |
| Profit before tax | (2.09) | (1.59) | 1.28 | 1.46 | 1.06 | 1.53 | 2.15 |
| Net profit | (2.22) | (1.44) | 1.14 | 0.88 | 0.61 | 0.96 | 1.29 |
| Net profit margin | -4.1% | -2.7% | +2.2% | +1.7% | +1.4% | +2.6% | +2.3% |
| EPS (₹) | (4.06) | (2.70) | 2.09 | 1.63 | 1.16 | 1.77 | 2.39 |
| Balance sheet | |||||||
| Total assets | 58.93 | 65.01 | 60.62 | 47.01 | 46.22 | 50.64 | 49.70 |
| Net worth | 28.55 | 30.75 | 32.21 | 31.08 | 30.19 | 29.57 | 28.60 |
| Total debt | 27.31 | 30.01 | 23.24 | 9.92 | 9.30 | 13.47 | 12.72 |
| Cash & bank | 0.20 | 0.22 | 0.68 | 0.33 | 0.26 | 0.54 | 0.72 |
| Net working capital | 39.17 | 43.39 | 46.90 | 40.20 | 38.37 | 41.38 | 38.50 |
| Cash flow | |||||||
| Cash from operations | 7.28 | 17.07 | 6.21 | 1.30 | 4.75 | 1.97 | 2.08 |
| Cash from investing | (2.41) | (11.61) | (7.92) | (0.18) | (0.17) | (0.89) | (1.31) |
| Cash from financing | (4.89) | (5.93) | 2.06 | (1.05) | (4.87) | (1.27) | (0.37) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.34 | 12.58 | 14.86 | 13.46 | 12.94 | 13.31 | 12.20 | 14.27 |
| Revenue growth (YoY) | +18.6% | -5.5% | +21.8% | -5.7% | -5.8% | - | - | - |
| Other income | 0.01 | 0.07 | 0.05 | 0.05 | 0.00 | 0.05 | 0.01 | 0.06 |
| Total expenses | 13.16 | 11.65 | 13.33 | 12.06 | 11.71 | 11.24 | 11.45 | 12.55 |
| EBITDA | 2.18 | 0.93 | 1.53 | 1.40 | 1.23 | 2.07 | 0.75 | 1.72 |
| EBITDA margin | +14.2% | +7.4% | +10.3% | +10.4% | +9.5% | +15.6% | +6.1% | +12.1% |
| Depreciation | 0.92 | 1.02 | 1.04 | 0.99 | 0.95 | 1.26 | 1.11 | 1.09 |
| Interest | 0.29 | 2.21 | 0.35 | 0.46 | 0.32 | 2.19 | 0.50 | 0.53 |
| Profit before tax | 0.98 | (2.23) | 0.19 | 0.00 | (0.04) | (1.33) | (0.85) | 0.16 |
| Tax | 0.25 | 0.09 | 0.05 | 0.00 | 0.00 | (0.15) | 0.00 | 0.04 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 14 Nov 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.34 | 12.58 | 14.86 | 13.46 | 12.94 | 13.31 | 12.20 | 14.27 |
| Revenue growth (YoY) | +18.6% | -5.5% | +21.8% | -5.7% | -5.8% | - | - | - |
| Other income | 0.01 | 0.07 | 0.05 | 0.05 | 0.00 | 0.05 | 0.01 | 0.06 |
| Total expenses | 13.16 | 11.65 | 13.33 | 12.06 | 11.71 | 11.24 | 11.45 | 12.55 |
| EBITDA | 2.18 | 0.93 | 1.53 | 1.40 | 1.23 | 2.07 | 0.75 | 1.72 |
| EBITDA margin | +14.2% | +7.4% | +10.3% | +10.4% | +9.5% | +15.6% | +6.1% | +12.1% |
| Depreciation | 0.92 | 1.02 | 1.04 | 0.99 | 0.95 | 1.26 | 1.11 | 1.09 |
| Interest | 0.29 | 2.21 | 0.35 | 0.46 | 0.32 | 2.19 | 0.50 | 0.53 |
| Profit before tax | 0.98 | (2.23) | 0.19 | 0.00 | (0.04) | (1.33) | (0.85) | 0.16 |
| Tax | 0.25 | 0.09 | 0.05 | 0.00 | 0.00 | (0.15) | 0.00 | 0.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 53.84 | 53.52 | 51.19 | 52.66 | 44.43 | 36.93 | 55.61 |
| Revenue growth | +0.6% | +4.6% | -2.8% | +18.5% | +20.3% | -33.6% | - |
| Other income | 0.17 | 0.12 | 0.13 | 0.13 | 0.04 | 0.09 | 0.09 |
| Total expenses | 48.59 | 47.08 | 46.03 | 48.26 | 39.95 | 31.82 | 49.69 |
| Employee cost | 11.75 | 11.86 | 11.33 | 11.19 | 10.77 | 9.98 | 10.67 |
| EBITDA | 5.25 | 6.44 | 5.16 | 4.40 | 4.48 | 5.11 | 5.92 |
| EBITDA margin | +9.8% | +12.0% | +10.1% | +8.4% | +10.1% | +13.8% | +10.7% |
| Depreciation | 4.00 | 4.25 | 1.39 | 1.30 | 1.53 | 1.55 | 1.55 |
| Interest | 3.51 | 3.90 | 2.62 | 1.77 | 1.93 | 2.12 | 2.31 |
| Profit before tax | (2.09) | (1.59) | 1.28 | 1.46 | 1.06 | 1.53 | 2.15 |
| Tax | 0.13 | (0.15) | 0.14 | 0.58 | 0.45 | 0.57 | 0.86 |
| Net profit | (2.22) | (1.44) | 1.14 | 0.88 | 0.61 | 0.96 | 1.29 |
| Net profit margin | -4.1% | -2.7% | +2.2% | +1.7% | +1.4% | +2.6% | +2.3% |
| EPS (₹) | (4.06) | (2.70) | 2.09 | 1.63 | 1.16 | 1.77 | 2.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| Reserves & surplus | 23.13 | 25.33 | 26.79 | 25.66 | 24.77 | 24.15 | 23.18 |
| Shareholders' funds (net worth) | 28.55 | 30.75 | 32.21 | 31.08 | 30.19 | 29.57 | 28.60 |
| Secured loans | 10.71 | 12.26 | 14.44 | 9.92 | 9.30 | 12.27 | 11.52 |
| Unsecured loans | 16.60 | 17.75 | 8.80 | 0.00 | 0.00 | 1.20 | 1.20 |
| Total debt | 27.31 | 30.01 | 23.24 | 9.92 | 9.30 | 13.47 | 12.72 |
| Total liabilities | 58.93 | 65.01 | 60.62 | 47.01 | 46.22 | 50.64 | 49.70 |
| Assets | |||||||
| Gross block | 45.17 | 42.94 | 31.47 | 23.78 | 23.62 | 23.46 | 23.38 |
| Net block | 18.22 | 19.98 | 12.77 | 6.47 | 7.61 | 8.97 | 10.44 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 40.65 | 43.48 | 42.52 | 37.24 | 32.26 | 36.23 | 32.20 |
| Sundry debtors | 18.28 | 18.40 | 18.80 | 20.59 | 19.53 | 22.40 | 23.35 |
| Cash & bank balances | 0.20 | 0.22 | 0.68 | 0.33 | 0.26 | 0.54 | 0.72 |
| Loans & advances | 0.90 | 0.87 | 3.31 | 1.20 | 1.22 | 1.44 | 1.67 |
| Total current assets | 60.03 | 62.97 | 65.31 | 59.36 | 53.27 | 60.61 | 57.94 |
| Total current liabilities | 20.86 | 19.58 | 18.41 | 19.16 | 14.90 | 19.23 | 19.44 |
| Net working capital | 39.17 | 43.39 | 46.90 | 40.20 | 38.37 | 41.38 | 38.50 |
| Total assets | 58.93 | 65.01 | 60.62 | 47.01 | 46.22 | 50.64 | 49.70 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.22 | 0.68 | 0.33 | 0.26 | 0.54 | 0.72 | 0.33 |
| Net cash from operating activities | 7.28 | 17.07 | 6.21 | 1.30 | 4.75 | 1.97 | 2.08 |
| Net cash from investing activities | (2.41) | (11.61) | (7.92) | (0.18) | (0.17) | (0.89) | (1.31) |
| Net cash from financing activities | (4.89) | (5.93) | 2.06 | (1.05) | (4.87) | (1.27) | (0.37) |
| Net change in cash | (0.02) | (0.47) | 0.35 | 0.07 | (0.28) | (0.18) | 0.40 |
| Closing cash | 0.20 | 0.22 | 0.68 | 0.33 | 0.26 | 0.54 | 0.72 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +0.6% | +4.6% | -2.8% | +18.5% | +20.3% | -33.6% | - |
| EBITDA growth | -18.5% | +24.8% | +17.3% | -1.8% | -12.3% | -13.7% | - |
| PBT growth | -31.5% | - | -12.3% | +37.7% | -30.7% | -28.8% | -24.0% |
| Net income growth | -54.2% | -226.3% | +29.6% | +44.3% | -36.5% | -25.6% | - |
| Revenue CAGR (3Y) | +0.7% | +6.4% | +11.5% | -1.8% | -7.5% | -11.2% | +1.7% |
| EBITDA CAGR (3Y) | +6.1% | +12.9% | +0.3% | -9.4% | -6.0% | +4.5% | +6.7% |
| Profitability & leverage | |||||||
| Net income margin | -4.1% | -2.7% | +2.2% | +1.7% | +1.4% | +2.6% | +2.3% |
| Return on capital employed | +2.3% | +3.7% | +7.2% | +7.0% | +6.2% | +7.3% | +9.7% |
| Return on net worth | -7.4% | -4.6% | +3.6% | +2.9% | +2.1% | +3.3% | +4.6% |
| Debt / equity | 0.97 | 0.85 | 0.52 | 0.31 | 0.38 | 0.45 | 0.46 |
| Long-term debt / equity | 0.58 | 0.42 | 0.14 | 0.00 | 0.02 | 0.04 | 0.04 |
| Interest cover | 280.80 | 178.08 | 69.50 | 57.10 | 65.42 | 59.55 | 52.86 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.22 | 1.44 | 1.85 | 2.22 | 1.89 | 1.58 | 2.86 |
| Inventory turnover | 1.28 | 1.24 | 1.28 | 1.52 | 1.30 | 1.08 | 1.79 |
| Debtors turnover | 2.94 | 2.88 | 2.60 | 2.63 | 2.12 | 1.61 | 2.52 |
| EPS (₹) | (4.06) | (2.70) | 2.09 | 1.63 | 1.16 | 1.77 | 2.39 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 52.63 | 56.70 | 59.40 | 57.31 | 55.67 | 54.52 | 52.74 |
To see the full year-wise statements and ratios of Centenial Surgical Suture Limited, buy the company report.
Board of directors of Centenial Surgical Suture Limited
Centenial Surgical Suture has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha Raghunandan Kashikar | Whole-Time Director | 28 Sep 2015 | 11 Years 1 Months | Current |
| Devraj Poojary | Whole-Time Director | 01 Feb 2011 | 15 Years 9 Months | Current |
| Vijay Kalidas Majrekar | Managing Director | 20 Jun 1995 | 31 Years 4 Months | Current |
| Neel Mukesh Vora | Director | 09 Jan 2017 | 9 Years 10 Months | Current |
| Akash Sunil Modi | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Ridhima Bhushan Limaye | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Centenial Surgical Suture Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pregna International Limited | ₹58.91 Cr (FY 2024) | -34.0% | Mumbai, Maharashtra, India | |||
| Centenial Surgical Suture Limitedthis company | ₹53.84 Cr (FY 2026) | -₹2.22 Cr | -4.1% | 0.6% | 238 | Thane, Maharashtra, India |
| Swear Healthcare Private Limited | ₹52.49 Cr (FY 2024) | -18.0% | Agra, Uttar Pradesh, India | |||
| Voxtur Bio Limited | ₹51.38 Cr (FY 2024) | 38.0% | Vasai, Maharashtra, India |
To see the full peer comparison of Centenial Surgical Suture Limited, buy the company report.
Auditor
Centenial Surgical Suture Limited is audited by MAHESH CHANDRA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHESH CHANDRA & ASSOCIATES | FY 2023 | 112334W |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 46.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 53.10%.
Mar 2026
QUARTER
46.90% Promoters
53.10% Retail & Others
Promoter holding - history
Now 46.90% · Mar 2026High 46.90% · Jun 2025Low 46.90% · Jun 2025
Shareholding trend - last 6 quarters
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 46.90% | 46.90% | 46.90% | 46.90% |
| Public | 53.10% | 53.10% | 53.10% | 53.10% |
Charges & borrowings
Open charges
₹19.25 Cr
Satisfied charges
₹38.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2019 | 100317642 | Canara Bank | ₹19.25 Cr | Open | |
| 31 Dec 2018 | 100232574 | Others | ₹19.25 Cr | Satisfied | |
| 26 Dec 2000 | 80003748 | Canara Bank | ₹19.25 Cr | Satisfied |
To see the full charge records of Centenial Surgical Suture Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Centenial Surgical Suture Limited has 12 deals on record (8 secondary share transfers, 4 market trades); the latest was in June 2023.
Total deals
12
Secondary share transfers
8
Market trades
4
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | Market trade | ₹65.9 Lakh | Buyer: an individual Seller: an individual |
| May 2023 | Market trade | ₹37.4 Lakh | Buyer: an individual Seller: Shree Bhuvanakaram Tradinvest Pvt Ltd |
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Others-Centenial Surgical Suture Limited |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Others-Centenial Surgical Suture Limited |
| Oct 2015 | Market trade | ₹10.8 Lakh | Seller: Volga International Limited |
To see the full deal history of Centenial Surgical Suture Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Centenial Surgical Suture Limited has 14 court cases on record: 11 filed by Centenial Surgical Suture, 3 filed against it. 4 cases are pending and 10 are disposed.
Total cases
14
Filed by the company
11
Filed against the company
3
Pending
4
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 3 | 4 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Comp. ULP) | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln IDA) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Asstt Registrar of Companies Ma | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMONS FOR JUDGT) | Filed by the company against an individual | Disposed |
To see the full case history of Centenial Surgical Suture Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Centenial Surgical Suture Limited was last rated by Crisil on 28 Aug 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 28 Aug 2020 |
To see the full credit ratings and regulatory alerts of Centenial Surgical Suture Limited, buy the company report.
MSME payment delays
Centenial Surgical Suture Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 2,053 overdue payments to 35 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 35)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Akshay Printers | |||
| Surgi Pack India Private Limited | |||
| Rajdhani Book and Paper Products Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Centenial Surgical Suture Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Centenial Surgical Suture Limited has a workforce of 238 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
238
Active EPFO establishments
1
Employee growth
-6.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 238 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Centenial Surgical Suture Limited, buy the company report.
GST
Centenial Surgical Suture has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC4639G1ZR | Maharashtra | Active | 01 Jul 2017 |
| 29AAACC4639G1ZN | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Centenial Surgical Suture Limited, buy the company report.
Recent activity
Centenial Surgical Suture Limited has 21 board changes on record since 1995: 14 appointments and 7 cessations. The latest: Akash Sunil Modi was appointed as Director on 01 Apr 2024.
Filing
Centenial Surgical Suture Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
AGM
Centenial Surgical Suture Limited last Annual general meeting of members was held on 28 Jul 2025 as per latest MCA records.
Appointed
Akash Sunil Modi was appointed as Director.
Appointed
Anuj Vipulbhai Shah was appointed as Director.
Appointed
Ridhima Bhushan Limaye was appointed as Director.
Ceased
Bhushan Suhas Limaye ceased to be Director.
Ceased
Jagadish Bhoja Shetty ceased to be Director.
Ceased
Sunil Chimanlal Modi ceased to be Director.
Charges
A charge registered on 31 Dec 2018 via Charge ID 100232574 with Others was fully satisfied on 29 Sep 2021.
Charges
A charge with Canara Bank amounted to Rs. 19.25 Cr with Charge ID 100317642 was registered on 31 Dec 2019.
Charges
A charge registered on 26 Dec 2000 via Charge ID 80003748 with Canara Bank was fully satisfied on 29 Jul 2019.
Charges
A charge with Others amounted to Rs. 19.25 Cr with Charge ID 100232574 was registered on 31 Dec 2018.
18 earlier events are in the company report.
News
Frequently asked questions
Centenial Surgical Suture is an active public limited company based in Thane, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 20 June 1995 (31+ years old) and is registered under CIN L99999MH1995PLC089759. Listed on BSE: 531380.
Centenial Surgical Suture reported revenue of ₹53.84 Cr for FY 2025-26 (up 0.6% YoY) based on standalone financials.
Centenial Surgical Suture has 7 current directors:
- Vijay Kalidas Majrekar - Managing Director
- Anuradha Raghunandan Kashikar - Whole-Time Director
- Devraj Poojary - Whole-Time Director
- Neel Mukesh Vora - Director
- Akash Sunil Modi - Director
- Ridhima Bhushan Limaye - Director
- Anuj Vipulbhai Shah - Director
The latest financial statements of Centenial Surgical Suture on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 28 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Centenial Surgical Suture is 27AAACC4639G1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAACC4639G1ZN (Karnataka).
The CIN (Corporate Identification Number) of Centenial Surgical Suture is L99999MH1995PLC089759. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Centenial Surgical Suture is a listed company as per MCA records. Its shares are listed on BSE (code: 531380).
Centenial Surgical Suture has 14 court cases on record: 11 filed by the company and 3 filed against it. 4 are pending. Most are in the district courts.
Centenial Surgical Suture was incorporated on 20 June 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Centenial Surgical Suture has 12 deals on record (8 secondary share transfers, 4 market trades); the latest was in June 2023.
The peers of Centenial Surgical Suture by revenue are Pregna International Limited, Swear Healthcare Private Limited, Voxtur Bio Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akash Sunil Modi was appointed as Director on 01 Apr 2024. Anuj Vipulbhai Shah was appointed as Director on 01 Apr 2024. Ridhima Bhushan Limaye was appointed as Director on 01 Apr 2024. Centenial Surgical Suture has 21 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages